Perceptronix - Early Diagnosis, Better Outcomes
   
 

Our Management Team

Bojana Turic, MD Director, President & CEO
Alexei Doudkine, PhD Clinical & Business Development
Jasenka Matisic, MD - Laboratory Director


Management

 

Bojana Turic, MD Director, President & CEO

As CEO of PMI Labs, Dr. Turic's extensive experience andproven ability to lead will be instrumental in the expansion of service and continued commercialization of innovative technology for early cancer detection products. Prior to being appointed CEO, Dr. Turic served as Vice President and COO. As one of the senior scientists of PMI Labs when it was founded in 1999, she has led the Company through significant clinical and regulatory milestones including, positioning the company as a world leader in early cancer diagnostic technologies, the development of strategic commercialization alliances, and execution of the company’s first commercial agreements. Dr. Turic completed her MD at the University of Sarajevo, Bosnia and Herzegovina where she held the position of Assistant Professor of Medical Microbiology.

Alexei Doudkine, PhD Clinical & Business Development

Alexei Doudkine, Ph.D. is a Director of Business Development at Perceptronix, focusing on new business opportunities, partnerships and collaborations. Previously Dr. Doudkine served as Director of Quantitative Pathology Products, managing development of company’s automated image cytometry devices and quantitative cytology services. Dr. Doudkine has over 20 years of experience in medical device industry developing novel imaging and spectroscopy technology for various biomedical applications. He is an author or co-author of more than 20 papers and co-inventor in several patents on application of digital imaging technology to early detection of cancer. Dr. Doudkine holds PhD in Computer Science from St. Petersburg Electrical Engineering University (Russia) and MSc in Applied Mathematics from St. Petersburg State University.

 

News and Events